Bruker expects first-quarter revenue to be $795 million to $800 million, ahead of Wall Street expectations. Analysts polled by FactSet are forecasting $758.4 million in quarterly revenue. The ...

Bruker Corporation (Nasdaq: BRKR) today announced preliminary revenue for the first quarter ended March 31, 2025, in a range of $795 million to $800 million, comparing favorably to the Company’s ...

At the ESCMID Global 2025 conference, Bruker´s Microbiology and Infection Diagnostics division is announcing the expansion of ...

Controlling film thickness to precise specifications is essential for ensuring high yield in high-performance devices.

Barclays analyst Luke Sergott lowered the firm’s price target on Bruker (BRKR) to $50 from $60 and keeps an Overweight rating on the shares as ...

Bruker Corporation’s BRKR share price has dipped by 11.48%, which has investors questioning if this is right time to buy.

Bruker Corporation ( NASDAQ:BRKR ), is not the largest company out there, but it received a lot of attention from ...

Detailed price information for Mettler-Toledo International (MTD-N) from The Globe and Mail including charting and trades.

Discover how Bruker’s BRAVO handheld Raman spectrometer is transforming material analysis with advanced fluorescence suppression and more.

Building on the success of its 1.0-1.2 GHz systems, Bruker's 1.3 GHz NMR spectrometer offers unprecedented resolution and ...

The 'Multi-Talent' uses standard 5 mm NMR samples, includes gradient spectroscopy, with options for adjustable sample ...